A 3-Arm Study Comparing the Efficacy of Anti-Reflux Reconstruction Protocols After Laparoscopic Proximal Gastrectomy
1 other identifier
interventional
180
1 country
1
Brief Summary
The efficacy of three different alimentary reconstruction methods after proximal gastrectomy will be investigated in this study in a prospective, multicenter, randomized controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2024
CompletedFirst Submitted
Initial submission to the registry
March 29, 2024
CompletedFirst Posted
Study publicly available on registry
April 4, 2024
CompletedApril 30, 2024
March 1, 2024
4 years
March 29, 2024
April 28, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of reflux esophagitis
At 1 year after LPG
Secondary Outcomes (5)
Incidence of anastomotic leakage
At 1 year after LPG
Incidence of anastomotic stenosis
At 1 year after LPG
Operative time
Intraoperative
Intra-operative blood loss
Intraoperative
Overall survival, and disease-free survival
At 1 and 3 years after LPG
Study Arms (3)
laparoscopic proximal gastrectomy with single-tract jejunal interposition reconstruction
EXPERIMENTALlaparoscopic proximal gastrectomy with double-tract reconstruction
ACTIVE COMPARATORlaparoscopic proximal gastrectomy with tube-like stomach reconstruction
ACTIVE COMPARATORInterventions
laparoscopic proximal gastrectomy with single-tract jejunal interposition (LPG-STJI) versus double-tract reconstruction (LPG-DTR) versus tube-like stomach reconstruction (LPG-TLR).
Eligibility Criteria
You may qualify if:
- Age between 18-75 years old, male or female;
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 (indicating fully active and able to continue all predisease activities without restriction) or 1 (indicating restricted in physically strenuous activities but ambulatory and able to perform work of a light or sedentary nature);
- American Society of Anesthesiology physical status classification of I (indicating normal and healthy), II (indicating mild systemic disease), or III (indicating severe systemic disease);
- Pathological diagnosis of preoperative endoscopic biopsy: the tumor is located in the upper 1/3 of the stomach (including the esophagogastric junction), and the clinical staging of gastric cancer Ia and Ib (T1N0M0, T1N1M0, and T2N0M0) (14) according to the eighth edition of the AJCC;
- Patients without contraindications to surgery;
- Voluntary participation by signing the written informed consent form approved by the institutional review board before study participation;
You may not qualify if:
- Receipt of chemotherapy or radiotherapy for the treatment of GC before either surgical procedure
- Combined resection required due to other diseases (except cholecystectomy).
- History of cancer or concurrent cancer in other organs.
- Previous or current receipt of treatment for systemic inflammatory disease or history of gastrectomy.
- Patients with coagulation dysfunction which could not be corrected;
- Vulnerable status (eg, lacking decision-making capacity, pregnant, or planning to become pregnant).
- Receipt of chemotherapy or radiotherapy before either surgical procedure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jiajie Zhou
Yangzhou, China
Related Publications (1)
Tian Z, Cheng Y, Wang Y, Ren J, Wang S, Wang D. A 3-Arm case-matched analysis of anti-reflux reconstruction methods after laparoscopic proximal gastrectomy - Single tract jejunal interposition vs double tract reconstruction vs tube-like stomach reconstruction. Eur J Surg Oncol. 2025 Feb;51(2):109482. doi: 10.1016/j.ejso.2024.109482. Epub 2024 Nov 19.
PMID: 39580964DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
March 29, 2024
First Posted
April 4, 2024
Study Start
January 1, 2020
Primary Completion
December 31, 2023
Study Completion
March 15, 2024
Last Updated
April 30, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share